Substance: boldenone undecylenate
Brand: maxtreme
Package: 10 ampoules (100mg/ml)


Bold-One is a steroid preparation manufactured by Maxtreme Pharma. The base ingredient of this drug is boldenone undecylenate. This component is also known as Equipoise. It has a long history of use and was originally used in veterinary medicine. However, after different studies, it became clear that it can also be used by humans. Today, the main areas of application for Equipoise are sports and training.

Equipoise Effects

One of the main positive features of the product is its low androgenic activity, half that of testosterone. In this case, the anabolic effect is similar to the anabolic classification of testosterone. The composition of the component is also similar to methandienone since initially, boldenone undecylenate was developed as its direct analog. However, they have big differences, like other steroids based on Boldenone. The great advantage of the drug is its availability and low cost.

Among the main properties, these benefits should be highlighted:

  • Slow but high-quality gain of muscle mass
  • Increased muscle strength and endurance
  • Increased appetite.

Equipoise Application and Dosage

Maxtreme boldenone in ampoules has a concentration of 100mg per 1ml. The injections can reduce the damage done to the liver. Many novice athletes are afraid to take steroids in this way because they are not completely familiar with its reactions in the body. However, when used correctly, they are quite safe.

Injections are given in a cycle of no more than 2.5 months. After that, this agent loses its effectiveness and starts to do damage. The weekly dose is up to 800 mg. This is the maximum dose that is recommended when taking this medication.The cycle should start at 400mg per week to follow the body's reaction before increasing the dose further.`

Additional Information


boldenone undecylenate


10 ampoules (100mg/ml)




There are no reviews yet.

Be the first to review “Bold-One”

Your email address will not be published. Required fields are marked *